Imaging Neurotoxicity: Is a Picture Worth a Thousand Words?

References

1. ↵
   Neuwalt EA, Guastadisegni PE, Várallyay P, Doolittle ND. Imaging changes and cognitive outcome in primary CNS lymphoma after enhanced chemotherapy delivery. AJNR Am J Neuroradiol 2005;26:00–00
2. ↵
   Armstrong CL, Hunter JV, Ledakis GE, et al. Late cognitive and radiographic changes related to radiotherapy. Neurology 2002;59:40–48

   Abstract/FREE Full Text
3. Postma TJ, Klein M, Verstappen CCP, et al. Radiotherapy-induced cerebral abnormalities in patients with low-grade glioma. Neurology 2002;59:121–123

   Abstract/FREE Full Text
4. Fliessbach K, Urbach H, Helmstaedter C, et al. Cognitive performance and magnetic resonance imaging findings after high-dose systemic and intraventricular chemotherapy for primary central nervous system lymphoma. Arch Neurol 2003;60:563–568

   CrossRefPubMedWeb of Science
5. ↵
   Correa DD, DeAngelis LM, Shi W, et al. Cognitive functions in survivors of primary central nervous system lymphoma. Neurology 2004;62:548–555

   Abstract/FREE Full Text
6. ↵
   Desmond DW. Cognition and white matter lesions. Cerebrovasc Dis 2002;13:53–57

   Abstract/FREE Full Text
7. ↵
   Mulhern RK, White HA, Glass JO, et al. Attentional functioning and white matter integrity among survivors of malignant brain tumors of childhood. J Int Neuropsychol Soc 2004;10:180–189

   CrossRefPubMedWeb of Science
8. ↵
   Reddick WE, White HA, Glass JO, et al. Developmental model relating white matter volume to neurocognitive deficits in pediatric brain tumor survivors. Cancer 2003;97:2512–2519

   CrossRefPubMedWeb of Science
9. ↵
   Khong PL, Kwong DL, Chan GC, et al. Diffusion-tensor imaging for the detection and quantification of treatment-induced white matter injury in children with medulloblastoma: a pilot study. AJNR Am J Neuroradiol 2003;24:734–740

   Abstract/FREE Full Text